SBFM FY 2015 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1,708

Gross Profit

-$383,000-22423.9% margin

Operating Income

-$780,000-45667.4% margin

Net Income

-$2M-96779.9% margin

EPS (Diluted)

$-1652908.00

Cash Flow

Operating Cash Flow

-$867,644

Free Cash Flow

-$1M

Stock-Based Comp.

$116,500

Balance Sheet

Total Assets

$673,261

Total Liabilities

$1M

Stockholders' Equity

-$597,045

Cash & Equivalents

$50,798

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1,708	$0	—
Gross Profit	-$383,000	-$263,000	-45.6%
Operating Income	-$780,000	-$2M	+55.6%
Net Income	-$2M	-$2M	+14.5%